Topics & Trends is Pangaea’s long running, definitive bi-monthly update on the Canadian pharma landscape. Whether you’re looking to establish your company’s brands across Canada’s diverse regional markets or looking to make a strategic move within the marketplace, this report offers the insights you need to know.

Inside Trade is Pangaea’s monthly trade focused publication covering the latest movements of industry heavyweights, marketing initiatives, and regulatory changes. If it concerns pharma product supply and distribution, it’s covered by Inside Trade.

Globally, over 60% of pharmaceutical industry growth can be attributed to specialty care brands. Pangaea recently interviewed a cross-range of executives in specialty and primary care pharmaceutical markets to understand how this market differs from primary care, what it takes to be successful and how the HR function can help ensure that success.

In their simplest form, SEBs are biologics — drugs created by bio- logical processes — with a demonstrated similarity to a previously approved biologic drug. Read more to find out how the regulatory environment and commercial models are unfolding and what impact is expected on the biologic market.

There has been a great deal of publicity on the new and expanded role of Pharmacists in the selection of pharmaceuticals across Canada. This article will clarify exactly what has changed and what the Pharmacist is empowered to do.

Quebec is undergoing its own transformation. This article highlights the changes and the implications for pharmaceuticals.

Executives in the hospital channel are dealing with significant and largely unmanageable forces that are shaping their decisions. In this atmosphere, it is important to know what senior health executives, who are now more involved in the buying decision, are looking for, in addition to good pricing.

We conducted research with 22 senior executives from 12 companies on the role of emotional intelligence (EI) in the Canadian research and development pharmaceutical industry, and the results were eye opening! We concluded there is a real risk that many companies are missing the boat on a genuine opportunity to gain a competitive edge.

Amgen approached Pangaea 11 years ago and asked that we provide strategic council and tactical support in the areas of business development, new product launches and distributor & pharmacy chain relations. When we were initially approached by Amgen, they wanted to establish a strong presence with channel customers and make sure their investments led to a tangible ROI. Our dedicated trade team of trade relations specialists assisted Amgen’s internal Supply Chain group to meet these goals.

The generic landscape has been evolving quickly over the past year and a half and Hoffmann-LaRoche Limited (Roche) needed some in depth expertise to explain where government policies were trending and what it meant for their specialty brands that were soon coming off patent.